Clinical Trials · NCT01455441
The Effects of Physical Training and GLP-1 Receptor Agonist Liraglutide Treatment in Patients With Type 2 Diabetes
- Phase
- Phase 4
- Recruitment status
- Completed
- Sponsor
- Tina Vilsboll
- Enrollment
- 40
- Start date
- Oct 2011
- Locations
- 1 site, Denmark
- Primary endpoint
- HbA1c